| Autor: |
Geers D; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Gommers L; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Tan NH; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Bogers S; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen, Netherlands; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands., Grifoni A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA., Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037, USA; Department of Medicine, University of California, San Diego (UCSD), La Jolla, CA 92037, USA., Boerma A; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen, Netherlands., Visscher F; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, Groningen, Netherlands., Richard M; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Funk M; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Zaeck LM; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., van der Kuy PHM; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Haagmans BL; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., Koopmans MP; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands., de Vries RD; Department of Viroscience, Erasmus University Medical Center, Rotterdam 40 3015GD, Netherlands. Electronic address: r.d.devries@erasmusmc.nl. |
| Abstrakt: |
Competing Interests: AS is a consultant for AstraZeneca, Calyptus Pharmaceuticals, Darwin Health, EmerVax, EUROIMMUN, F Hoffman-La Roche, Fortress Biotech, Gilead Sciences, Granite Bio, Gritstone Oncology, Guggenheim Securities, Moderna, Pfizer, RiverVest Venture Partners, and Turnstone Biologics. AG is a consultant for Pfizer. La Jolla Institute for Immunology has filed for patent protection for various aspects of T-cell epitope and vaccine design work. All other authors declare no competing interests. |
